Results 11 to 20 of about 10,362 (160)

Medroxyprogesterone acetate improves propionic acid-induced autism rat model and magnetic resonance spectroscopic correlation

Bangladesh Journal of Pharmacology, 2022
The protective effect of medroxyprogesterone acetate on propionic acid-induced autism in rats was evaluated. For this purpose, 30 rats were divided into three groups.
Mehmet Fatih Bozkurt, Muhammad Nasir Bhaya, İbrahim Halil Sever, Bahattin Özkul, Oytun Erbaş   +4 more
doaj   +1 more source

Self-administered subcutaneous medroxyprogesterone acetate for improving contraceptive outcomes: a systematic review and meta-analysis

BMC Women's Health, 2021
Background Subcutaneous depot medroxyprogesterone acetate is an easy-to-use injectable contraceptive. A trained person can administer it, including women through self-injection.
Ashraf Nabhan, Farida Elshafeey, Luna Marion Mehrain, Rita Kabra, Amal Elshabrawy   +4 more
doaj   +1 more source

Depo Medroxyprogesterone Acetate (DMPA): Long-Term Effects on Menstrual Cycle Disorders

Indonesian Journal of Obstetrics and Gynecology, 2023
bjective: To determine the effect of the duration of using Depo Medroxyprogesterone Acetate (DMPA) on the Menstrual Cycle. Methods: This research is an analytical study of 102 patients who used DMPA for less than 1 year and more than 1 year and then ...
Nurhayati Nurhayati, Suhermi S, Sitti H. Hamang   +2 more
doaj   +1 more source

Progestins Inhibit Interleukin-1β-Induced Matrix Metalloproteinase 1 and Interleukin 8 Expression via the Glucocorticoid Receptor in Primary Human Amnion Mesenchymal Cells

Frontiers in Physiology, 2020
Preterm premature rupture of membranes is a leading cause of preterm births. Cytokine induced matrix metalloproteinase1 and interleukin 8 production from amnion mesenchymal cells may contribute to fetal membrane weakening and rupture.
William Marinello, Liping Feng, Terrence K. Allen   +2 more
doaj   +1 more source

The Risk of Infection Human Papilloma Virus Infection in Acceptors of Depot Medroxyprogesterone Acetate Contraceptions

Indonesian Journal of Obstetrics and Gynecology, 2018
Objective: Cervical cancer is the second most prevalent cancer in women around the world and the most common cancer in women causing death. This study aims to analyze the connection between infection of human papilloma virus (HPV) 16/18 and cervical ...
Baharuddin Aras, Mardiah Tahir, Sharvianty Arifuddin, Eddy Hartono, Maisuri T. Chalid   +4 more
doaj   +1 more source

Possible Participation of Adenine Nucleotide Translocase ANT1 in the Cytotoxic Action of Progestins, Glucocorticoids, and Diclofenac on Tumor Cells

Pharmaceutics, 2023
A comparative analysis of the cytostatic effects of progestins (gestobutanoyl, megestrol acetate, amol, dienogest, and medroxyprogesterone acetate), glucocorticoids (hydrocortisone, dexamethasone), and diclofenac on tumor cells was carried out in order ...
Darya Ulchenko, Lilia Miloykovich, Olga Zemlyanaya, Nikolay Shimanovsky, Tatiana Fedotcheva   +4 more
doaj   +1 more source

Lycorine sensitizes CD40 ligand-protected chronic lymphocytic leukemia cells to bezafibrate- and medroxyprogesterone acetate-induced apoptosis but dasatanib does not overcome reported CD40-mediated drug resistance

Haematologica, 2010
Background Tumor cells in chronic lymphocytic leukemia accumulate in the periphery through the proliferation of a minority of cells in lymph nodes.
Rachel E. Hayden, Guy Pratt, Mark T. Drayson, Chris M. Bunce   +3 more
doaj   +1 more source

Ovulation suppression following subcutaneous administration of depot medroxyprogesterone acetate

Contraception: X, 2022
Objectives: To characterize the relationship between serum medroxyprogesterone acetate (MPA) concentrations and ovulation suppression, and to estimate the risk of ovulation for investigational subcutaneous regimens of Depo-Provera CI (Depo-Provera) and ...
Douglas J. Taylor, Vera Halpern, Vivian Brache, Luis Bahamondes, Jeffrey T. Jensen, Laneta J. Dorflinger   +5 more
doaj   +1 more source

Subcutaneous depo-medroxyprogesterone acetate [PDF]

Journal of Family Planning and Reproductive Health Care, 2013
Since 2004, a micronised formulation of depo-medroxyprogesterone acetate (DMPA) that is delivered as a subcutaneous injection has been available. It is currently in clinical use in the USA and in nine countries throughout Europe.1 As of March 2013 this product is being marketed in the UK as Sayana® Press (Pfizer, UK).
openaire   +2 more sources

Combined high dose vitamin C and E increases oxidative stress and visceral fat mass in rats treated by depot-medroxyprogesterone acetate

Middle East Fertility Society Journal, 2016
Objective: This study was aimed to investigate the effect of combined vitamin C and E on serum leptin, visceral fat mass, and visceral fat oxidative stress in rats treated by depot-medroxyprogesterone acetate (DMPA).
Endang Sri Wahyuni, I. Wayan Arsana Wiyasa, Nurdiana Nurdiana   +2 more
doaj   +1 more source